udenafil

phosphodiesterase 5A ; Homo sapiens







20 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35396013 Lodenafil. 2022 1
2 26027619 PDE 5 inhibition with udenafil improves left ventricular systolic/diastolic functions and exercise capacity in patients with chronic heart failure with reduced ejection fraction; A 12-week, randomized, double-blind, placebo-controlled trial. 2015 Jun 1
3 24868160 Udenafil for the treatment of erectile dysfunction. 2014 1
4 24987176 Concentration-dependent differential effects of udenafil on viability, proliferation, and apoptosis in vascular endothelial and smooth muscle cells. 2014 May-Jun 1
5 25189168 Baseline MRA predicts the treatment response to vasodilator udenafil in patients with secondary Raynaud's phenomenon. 2014 Nov-Dec 1
6 23656343 Phosphodiesterase inhibitors in clinical urology. 2013 May 1
7 23785019 Efficacy and tolerability of udenafil in Turkish men with erectile dysfunction of psychogenic and organic aetiology: a randomized, double-blind, placebo-controlled study. 2013 Jul 1
8 23799908 ULTIMATE-SHF trial (UdenafiL Therapy to Improve symptoMAtology, exercise Tolerance and hEmodynamics in patients with chronic systolic heart failure): study protocol for a randomized, placebo-controlled, double-blind trial. 2013 Jun 22 1
9 26558086 Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: Current information and new horizons. 2013 Sep 1
10 22644853 Solid state of a new PDE-5 inhibitor DA-8159: characterization, dissolution, transformation. 2012 May 2
11 22946546 Udenafil improves exercise capacity in patients with chronic obstructive pulmonary disease: a prospective study. 2012 Aug 3
12 21054754 Activity of phosphodiesterase type 5 inhibitors in patients with lower urinary tract symptoms due to benign prostatic hyperplasia. 2011 Jun 1
13 21460862 Prevalence and medical management of erectile dysfunction in Asia. 2011 Jul 1
14 19660002 Effect of food on the pharmacokinetics of the oral phosphodiesterase 5 inhibitor udenafil for the treatment of erectile dysfunction. 2009 Jul 2
15 19860692 PDE5 inhibitors: in vitro and in vivo pharmacological profile. 2009 2
16 18197727 Looking to the future for erectile dysfunction therapies. 2008 1
17 18221288 The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction. 2008 Apr 3
18 18318773 Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects. 2008 Jun 2
19 16869121 Udenafil, a long-acting PDE5 inhibitor for erectile dysfunction. 2006 Jul 2
20 12510841 Mechanism of erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159. 2002 Dec 5